Definitive Healthcare Corp.
Definitive Healthcare Corp. (DH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
dh · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Hold
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$3.50
Consensus
$2.45
+178.6% upside
Low
$1.10
Median: $2.75 · Last Close: $0.88
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$2.45
178.6% upside
High Target
$3.5
298.0%
Low Target
$1.1
25.1%
Current Price
$0.88
as of today
Based on analyst price targets, the DH stock price prediction for the next 12 months ranges from $1.1 to $3.5. The consensus DH price forecast of $2.45 implies 178.6% upside from the current price of $0.88.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.89 | ↑ 0.92% |
1-day model range: $0.87–$0.91. Peak: $0.91 (+0.92%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · DH · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-30 | Barclays | Maintains | Underweight→Underweight |
| 2026-02-27 | Canaccord Genuity | Maintains | Hold→Hold |
| 2026-02-27 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2025-12-09 | Barclays | Maintains | Underweight→Underweight |
| 2025-11-10 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-08-08 | Stifel | Maintains | Buy→Buy |
| 2025-05-12 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-03-04 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-03-03 | Barclays | Maintains | Underweight→Underweight |
| 2025-01-16 | Needham | Maintains | Hold→Hold |
Wall Street analysts have recently issued updated ratings on Definitive Healthcare Corp. (DH) stock. Of the recent 68 rating actions, 3 were upgrades and 6 were downgrades. 15 analysts currently cover DH.
Analyst Recommendation Trends
DH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$250M
↑ 12.1% YoY
Revenue Next Year
$240M
↓ 4.3% YoY
EPS This Year
$0.34
EPS Next Year
$0.24
↓ 29.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast DH EPS of $0.34 for the current fiscal year, based on estimates from 10 analysts. The DH revenue forecast is $250M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DH stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DH price target is $2.45 (+178.6% upside), with an analyst consensus of Hold.
The DH short-term stock prediction for tomorrow is $0.89 (+0.92%). The DH stock prediction for 2030 projects a range of $0–$0.
Definitive Healthcare Corp. trades on NASDAQ under the ticker DH. The DH stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 20% of covering analysts.
Frequently asked questions
DH forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month DH price target is $2.45, with a high forecast of $3.50 and a low of $1.10. The median price target is shown in the chart above when available. This implies +178.6% potential upside from the current price of $0.88.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.